Evidence map›Paper›PMID 34472154›Full record

ArticleJournal of neuroendocrinology2021

Roles of fibroblast growth factor 21 in the control of depression-like behaviours after social defeat stress in male rodents.

Naoki Usui, Masahide Yoshida, Yuki Takayanagi, Naranbat Nasanbuyan, Ayumu Inutsuka, Hiroshi Kurosu, Hiroaki Mizukami, Yoshiyuki Mori, Makoto Kuro-O, Tatsushi Onaka

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Naoki UsuiDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Masahide YoshidaDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Yuki TakayanagiDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Naranbat NasanbuyanDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Ayumu InutsukaDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Hiroshi KurosuDivision of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Hiroaki MizukamiDivision of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Yoshiyuki MoriDepartment of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Shimotsuke, Japan.
Makoto Kuro-ODivision of Anti-aging Medicine, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Tatsushi OnakaDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.ORCID https://orcid.org/0000-0001-5666-9035
Jichi Medical University · JP

Funding

Japan Society for the Promotion of Science 17H04026Japan Society for the Promotion of Science 17K08573Japan Society for the Promotion of Science 17K08574Japan Society for the Promotion of Science 19H05026Japan Society for the Promotion of Science 19K06910Japan Society for the Promotion of Science 20H03419Japan Society for the Promotion of Science 20K07264Japan Society for the Promotion of Science 20K07278Kobayashi FoundationUrakami Foundation for Food and Food Culture Promotion
6 · The paper itself

Abstract

Fibroblast growth factor 21 (FGF21) modulates energy metabolism and neuroendocrine stress responses. FGF21 synthesis is increased after environmental or metabolic challenges. Detailed roles of FGF21 in the control of behavioural disturbances under stressful conditions remain to be clarified. Here, we examined the roles of FGF21 in the control of behavioural changes after social defeat stress in male rodents. Central administration of FGF21 increased the number of tyrosine hydroxylase-positive catecholaminergic cells expressing c-Fos protein, an activity marker of neurones, in the nucleus tractus solitarius and area postrema. Double in situ hybridisation showed that some catecholaminergic neurones in the dorsal medulla oblongata expressed β-Klotho, an essential co-receptor for FGF21, in male mice. Social defeat stress increased FGF21 concentrations in the plasma of male mice. FGF21-deficient male mice showed social avoidance in a social avoidance test with C57BL/6J mice (background strain of FGF21-deficient mice) and augmented immobility behaviour in a forced swimming test after social defeat stress. On the other hand, overexpression of FGF21 by adeno-associated virus vectors did not significantly change behaviours either in wild-type male mice or FGF21-deficient male mice. The present data are consistent with the view that endogenous FGF21, possibly during the developmental period, has an inhibitory action on stress-induced depression-like behaviour in male rodents.

Indexed as

catecholaminergic neuronesdepression-like behaviourFGF21nucleus tractus solitariussocial defeat stress

Identifiers

PMID34472154
PMCPMC9285091
OpenAlexW3190562399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.